Compare $VCNX vs $VIVS | Chartloom

Compare

$VCNX vs $VIVS

Vaccinex Inc · VivoSim Labs Inc

VCNX

Vaccinex Inc

VIVS

VivoSim Labs Inc

Compare $VCNX vs $VIVS

Comparing Vaccinex Inc and VivoSim Labs Inc

VCNXVaccinex Inc

VIVSVivoSim Labs Inc

VCNXVaccinex Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

5.4%

YTD performance

0.9%

52W performance

29.8%

FCF yield

-530.5%

VIVSVivoSim Labs Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-21.1%

YTD performance

-90.4%

52W performance

-94.3%

FCF yield

-466.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

VCNX

VIVS

Detailed metrics comparison

VCNX

Vaccinex Inc

VIVS

VivoSim Labs Inc

Market Cap

VCNX$3M

VIVS$2M

Enterprise Value

VCNX$2M

VIVS$502K

Price

VCNX$1.14

VIVS$0.18

P/E Ratio

VCNXN/A

VIVSN/A

P/S Ratio

VCNX5.08x

VIVS19.39x

EV/Sales

VCNX3.28x

VIVS4.48x

EV/EBITDA

VCNX0.00x

VIVS0.00x

P/B Ratio

VCNX1.15x

VIVS0.73x

P/FCF Ratio

VCNXN/A

VIVSN/A

EV/FCF

VCNX-0.12x

VIVS-0.05x

PEG Ratio

VCNXN/A

VIVSN/A

Forward P/E (NTM)

VCNXN/A

VIVSN/A

Forward P/S (NTM)

VCNXN/A

VIVSN/A

Revenue (TTM)

VCNX$601K

VIVS$112K

Revenue Growth (YoY)

VCNX5.4%

VIVS-21.1%

Forward Rev Growth

VCNX0.0%

VIVS0.0%

Gross Margin (TTM)

VCNX99.7%

VIVS83.9%

Operating Margin (TTM)

VCNX0.0%

VIVS0.0%

EBITDA Margin (TTM)

VCNX-3101.7%

VIVS-9943.8%

Net Margin (TTM)

VCNX-3100.5%

VIVS-11016.1%

FCF Margin (TTM)

VCNX-2696.8%

VIVS-9038.4%

Net Income (TTM)

VCNX$-19M

VIVS$-12M

FCF (TTM)

VCNX$-16M

VIVS$-10M

EPS (TTM)

VCNX-$5.78

VIVS-$2.35

ROE (TTM)

VCNX-14678.0%

VIVS-1556.0%

ROA (TTM)

VCNX-43375.0%

VIVS-17702.0%

ROIC (TTM)

VCNX-14238.0%

VIVS-1556.0%

Cash

VCNX$1M

VIVS$2M

Debt

VCNX$25K

VIVS$0

Net Cash/Debt

VCNX$1M

VIVS$2M

Current Ratio (TTM)

VCNX0.50x

VIVS1.70x

Quick Ratio (TTM)

VCNX0.38x

VIVS1.43x

Debt/Equity (TTM)

VCNX0.03x

VIVS0.00x

Debt/Assets (TTM)

VCNX0.0%

VIVS0.0%

Interest Coverage (TTM)

VCNXN/A

VIVSN/A

Net Debt/EBITDA (TTM)

VCNX0.00x

VIVS0.00x

Beta

VCNX0.73

VIVS1.57

52W Performance

VCNX29.8%

VIVS-94.3%

YTD Performance

VCNX0.9%

VIVS-90.4%

% from 52W High

VCNX-24.0%

VIVS-94.9%

% from 52W Low

VCNX267.7%

VIVS7.2%

Asset Turnover (TTM)

VCNX0.14x

VIVS0.02x

FCF Yield (TTM)

VCNX-530.5%

VIVS-466.1%

Earnings Yield (TTM)

VCNX-609.9%

VIVS-568.0%

Dividend Yield (TTM)

VCNXN/A

VIVSN/A

Rule of 40

VCNX-2,691.4

VIVS-9,059.5

EV/GP/RG

VCNXN/A

VIVSN/A

Ticker research

View VCNX research View VIVS research

Metric	VCNX Vaccinex Inc	VIVS VivoSim Labs Inc
Market & Valuation
Market Cap	$3M	$2M
Enterprise Value	$2M	$502K
Price	$1.14	$0.18
P/E Ratio	N/A	N/A
P/S Ratio	5.08x	19.39x
EV/Sales	3.28x	4.48x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.15x	0.73x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.12x	-0.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$601K	$112K
Revenue Growth (YoY)	5.4%	-21.1%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	99.7%	83.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-3101.7%	-9943.8%
Net Margin (TTM)	-3100.5%	-11016.1%
FCF Margin (TTM)	-2696.8%	-9038.4%
Net Income (TTM)	$-19M	$-12M
FCF (TTM)	$-16M	$-10M
EPS (TTM)	-$5.78	-$2.35
ROE (TTM)	-14678.0%	-1556.0%
ROA (TTM)	-43375.0%	-17702.0%
ROIC (TTM)	-14238.0%	-1556.0%
Financial Health
Cash	$1M	$2M
Debt	$25K	$0
Net Cash/Debt	$1M	$2M
Current Ratio (TTM)	0.50x	1.70x
Quick Ratio (TTM)	0.38x	1.43x
Debt/Equity (TTM)	0.03x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.73	1.57
52W Performance	29.8%	-94.3%
YTD Performance	0.9%	-90.4%
% from 52W High	-24.0%	-94.9%
% from 52W Low	267.7%	7.2%
Efficiency & Yields
Asset Turnover (TTM)	0.14x	0.02x
FCF Yield (TTM)	-530.5%	-466.1%
Earnings Yield (TTM)	-609.9%	-568.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,691.4	-9,059.5
EV/GP/RG	N/A	N/A
Ticker research	View VCNX research	View VIVS research

Valuation

P/S Ratio

VCNX

5.08x

VIVS

19.39x

EV/FCF

VCNX

-0.12x

VIVS

-0.05x

Growth & revenue

Revenue Growth TTM

VCNX

5.4%

VIVS

-21.1%

Forward Revenue Growth

VCNX

0.0%

VIVS

0.0%

Profitability & performance

Gross Margin

VCNX

99.7%

VIVS

83.9%

ROE

VIVS

-1556.0%

VCNX

-14678.0%

FCF Yield %

VIVS

-466.1%

VCNX

-530.5%

52-Week Performance

VCNX

29.8%

VIVS

-94.3%

Detailed metrics comparison

VCNX

Vaccinex Inc

VIVS

VivoSim Labs Inc

Market Cap

VCNX$3M

VIVS$2M

Enterprise Value

VCNX$2M

VIVS$502K

Price

VCNX$1.14

VIVS$0.18

P/E Ratio

VCNXN/A

VIVSN/A

P/S Ratio

VCNX5.08x

VIVS19.39x

EV/Sales

VCNX3.28x

VIVS4.48x

EV/EBITDA

VCNX0.00x

VIVS0.00x

P/B Ratio

VCNX1.15x

VIVS0.73x

P/FCF Ratio

VCNXN/A

VIVSN/A

EV/FCF

VCNX-0.12x

VIVS-0.05x

PEG Ratio

VCNXN/A

VIVSN/A

Forward P/E (NTM)

VCNXN/A

VIVSN/A

Forward P/S (NTM)

VCNXN/A

VIVSN/A

Revenue (TTM)

VCNX$601K

VIVS$112K

Revenue Growth (YoY)

VCNX5.4%

VIVS-21.1%

Forward Rev Growth

VCNX0.0%

VIVS0.0%

Gross Margin (TTM)

VCNX99.7%

VIVS83.9%

Operating Margin (TTM)

VCNX0.0%

VIVS0.0%

EBITDA Margin (TTM)

VCNX-3101.7%

VIVS-9943.8%

Net Margin (TTM)

VCNX-3100.5%

VIVS-11016.1%

FCF Margin (TTM)

VCNX-2696.8%

VIVS-9038.4%

Net Income (TTM)

VCNX$-19M

VIVS$-12M

FCF (TTM)

VCNX$-16M

VIVS$-10M

EPS (TTM)

VCNX-$5.78

VIVS-$2.35

ROE (TTM)

VCNX-14678.0%

VIVS-1556.0%

ROA (TTM)

VCNX-43375.0%

VIVS-17702.0%

ROIC (TTM)

VCNX-14238.0%

VIVS-1556.0%

Cash

VCNX$1M

VIVS$2M

Debt

VCNX$25K

VIVS$0

Net Cash/Debt

VCNX$1M

VIVS$2M

Current Ratio (TTM)

VCNX0.50x

VIVS1.70x

Quick Ratio (TTM)

VCNX0.38x

VIVS1.43x

Debt/Equity (TTM)

VCNX0.03x

VIVS0.00x

Debt/Assets (TTM)

VCNX0.0%

VIVS0.0%

Interest Coverage (TTM)

VCNXN/A

VIVSN/A

Net Debt/EBITDA (TTM)

VCNX0.00x

VIVS0.00x

Beta

VCNX0.73

VIVS1.57

52W Performance

VCNX29.8%

VIVS-94.3%

YTD Performance

VCNX0.9%

VIVS-90.4%

% from 52W High

VCNX-24.0%

VIVS-94.9%

% from 52W Low

VCNX267.7%

VIVS7.2%

Asset Turnover (TTM)

VCNX0.14x

VIVS0.02x

FCF Yield (TTM)

VCNX-530.5%

VIVS-466.1%

Earnings Yield (TTM)

VCNX-609.9%

VIVS-568.0%

Dividend Yield (TTM)

VCNXN/A

VIVSN/A

Rule of 40

VCNX-2,691.4

VIVS-9,059.5

EV/GP/RG

VCNXN/A

VIVSN/A

Ticker research

View VCNX research View VIVS research

Metric	VCNX Vaccinex Inc	VIVS VivoSim Labs Inc
Market & Valuation
Market Cap	$3M	$2M
Enterprise Value	$2M	$502K
Price	$1.14	$0.18
P/E Ratio	N/A	N/A
P/S Ratio	5.08x	19.39x
EV/Sales	3.28x	4.48x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.15x	0.73x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.12x	-0.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$601K	$112K
Revenue Growth (YoY)	5.4%	-21.1%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	99.7%	83.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-3101.7%	-9943.8%
Net Margin (TTM)	-3100.5%	-11016.1%
FCF Margin (TTM)	-2696.8%	-9038.4%
Net Income (TTM)	$-19M	$-12M
FCF (TTM)	$-16M	$-10M
EPS (TTM)	-$5.78	-$2.35
ROE (TTM)	-14678.0%	-1556.0%
ROA (TTM)	-43375.0%	-17702.0%
ROIC (TTM)	-14238.0%	-1556.0%
Financial Health
Cash	$1M	$2M
Debt	$25K	$0
Net Cash/Debt	$1M	$2M
Current Ratio (TTM)	0.50x	1.70x
Quick Ratio (TTM)	0.38x	1.43x
Debt/Equity (TTM)	0.03x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.73	1.57
52W Performance	29.8%	-94.3%
YTD Performance	0.9%	-90.4%
% from 52W High	-24.0%	-94.9%
% from 52W Low	267.7%	7.2%
Efficiency & Yields
Asset Turnover (TTM)	0.14x	0.02x
FCF Yield (TTM)	-530.5%	-466.1%
Earnings Yield (TTM)	-609.9%	-568.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,691.4	-9,059.5
EV/GP/RG	N/A	N/A
Ticker research	View VCNX research	View VIVS research